Skip to content

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06227611
Enrollment
16
Registered
2024-01-29
Start date
2021-05-04
Completion date
2029-05-04
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.

Interventions

None listed

Sponsors

Fondazione G.B. Bietti, IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness

Exclusion criteria

* age\<18 years * unable to read, understand and sign the written informed consent * unable to perform visual field test * advanced glaucoma with C/D\>0.7 * other causes of optic neuropathies * retinal or macular diseases * lens or corneal opacities * spherical refractive defect \>± 6D * cylindric refractive defect \>± 3D

Design outcomes

Primary

MeasureTime frameDescription
the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect12 monthcentral visual field is defined by the presence of a cluster of three test locations with significantly reduced sensitivity in a hemifield fo the pattern deviation plot.

Secondary

MeasureTime frameDescription
the agreement between 24-2c HFA and G1 Octopus in detecting central visual field defect12 monthcentral visual field is defined by the presence of a cluster of three test locations with significantly reduced sensitivity in a hemifield fo the pattern deviation plot.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026